Organic electroluminescent device
摘要
說明書
According to one embodiment of the present specification, A1 is a substituted or unsubstituted pyridine group; a substituted or unsubstituted pyrrole group; a substituted or unsubstituted pyrimidine group; a substituted or unsubstituted pyridazine group; a substituted or unsubstituted imidazole group; a substituted or unsubstituted pyrazole group; a substituted or unsubstituted oxazole group; a substituted or unsubstituted isoxazole group; a substituted or unsubstituted triazole group; a substituted or unsubstituted triazole group; a substituted or unsubstituted isothiazole group; a substituted or unsubstituted oxadiazole group; a substituted or unsubstituted thiadiazole group; a substituted or unsubstituted dithiazole group; a substituted or unsubstituted tetrazole group; a substituted or unsubstituted diazine group; a substituted or unsubstituted oxazine group; a substituted or unsubstituted triazine group; a substituted or unsubstituted isoquinoline group; a substituted or unsubstituted quinoline group; a substituted or unsubstituted quinol group; a substituted or unsubstituted quinazoline group; a substituted or unsubstituted quinoxaline group; a substituted or unsubstituted acridine group; a substituted or unsubstituted phenanthridine group; a substituted or unsubstituted diazanaphthalene group; a substituted or unsubstituted indole group; a substituted or unsubstituted benzothiazole group; a substituted or unsubstituted benzoxazole group; a substituted or unsubstituted benzimidazole group; a substituted or unsubstituted carbazole group; a substituted or unsubstituted benzocarbazole group; a substituted or unsubstituted phenazine group; or a substituted or unsubstituted phenoxazine group.
